Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Thomas Forst

3PUBLICATIONS
12CO-AUTHORS
Nutrigenomics and personalised nutritionPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Feb 11, 2025
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes.

Thomas Forst, Christophe De Block, Stefano Del Prato

|Oct 07, 2024
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity.

Nadine Beetz, Brigitte Kalsch, Thomas Forst

|Jul 29, 2024
The role of incretin receptor agonists in the treatment of obesity.

Thomas Forst, Christophe De Block, Stefano Del Prato

Pageof 1

Frequent Collaborators

2 joint publications

Christophe De Block

2 joint publications

Stefano Del Prato

2 joint publications

Juan Frias

2 joint publications

Anne Lautenbach

2 joint publications

Bernhard Ludvik

2 joint publications

Chantal Mathieu

2 joint publications

Timo D Müller

2 joint publications

Oliver Schnell

1 joint publications

Sara Armani

1 joint publications

Nadine Beetz

Frequent Collaborators

2 joint publications

Christophe De Block

2 joint publications

Stefano Del Prato

2 joint publications

Juan Frias

2 joint publications

Anne Lautenbach

Top Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on : Apr 04, 2025

270
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

11.9K
See more related videos

Top Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on : Apr 04, 2025

270
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

11.9K
See more related videos